Single and multiple dose study of H021 in healthy people
Part of Digestive system clinical trials.
This trial tests an investigational drug called H021 in healthy volunteers. It aims to understand how the body processes the drug at different dose levels. This study may help determine safe dosing for future trials.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You cannot smoke or use nicotine products for at least 3 months before the screening.
- Your weight must be within a healthy range based on your height (body mass index between 18.5 and 32).
- You must be in good health, without any major medical conditions or recent illnesses.
- Women must either be postmenopausal or surgically sterile, or willing to use effective birth control. Men must not donate sperm for 90 days after the last dose.
- You cannot have used any medications or been in other clinical trials within specified timeframes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This early-phase study tests an experimental drug called HXN6005 in healthy adults to see how safe it is and how the body handles it. It's looking for volunteers who are generally healthy and meet basic age and weight requirements.
This trial tests an experimental tablet called H021 for people with moderate to severe Crohn's disease that hasn't responded well to other treatments. The goal is to see if it can reduce inflammation and improve symptoms.
This is an early-stage study testing a new drug called TL-003 to see if it's safe and how the body processes it. Researchers will first test it in healthy volunteers, then in people with ulcerative colitis (an inflammatory bowel disease) to understand if it might help reduce inflammation.
This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.